Get support for accessing SKYCLARYS with Biogen REACH

Patients featured are paid spokespersons for Biogen.

REACH can help you explore your options

REACH is an access resource committed to helping people with Friedreich ataxia (FA) receive SKYCLARYS quickly, easily, and affordably.

Your doctor must complete and submit a Start Form before you can access REACH support.* Once enrolled in REACH, you will be assigned a Family Access Manager (FAM) and a Lead Case Manager (LCM).

*You are not required to enroll in Biogen REACH to receive a prescription for SKYCLARYS.

Your Biogen FAM

This will be your primary point of contact for the REACH program, providing support by working through the logistics associated with getting your SKYCLARYS prescription. FAMs work closely with patients and prescribers to help in the steps required to access therapy, including:

  • Prior authorization and reauthorization
  • Specialty pharmacy support (if applicable)
  • Patient support resources and tools throughout the treatment journey
  • Education and answers to questions about the disease, financial support, and insurance

FAMs stay in touch throughout the treatment journey to provide the best possible patient experience.

Your Biogen LCM

This is your treatment case manager, who keeps track of all your information through every step of your journey. Some things they can help with include:

  • Initiating contact with you once your Start Form is received
  • Coordinating your first shipments of SKYCLARYS
  • Acting as an intermediary with the specialty pharmacy
  • Managing patient support services such as financial assistance enrollment and mobile labs

Find your local FAM

Enter your ZIP code to locate a FAM in your area who can help you with accessing your SKYCLARYS prescription. You must have a prescription from your doctor for your FAM to be able to share resources. If you’re reaching out to your FAM via phone, please call between 9:00 am and 5:00 pm in your local time zone.

Your SKYCLARYS prescription will be delivered to you by a specialty pharmacy

SKYCLARYS is not available at retail pharmacies. The Biogen REACH exclusive specialty pharmacy, Biologics, will contact you to confirm the delivery address and collect any copayments or coinsurance that may be required for each monthly supply of your SKYCLARYS prescription.

The specialty pharmacy may also contact you to inquire about your:

  • SKYCLARYS prescription
  • Insurance benefits and copays
  • Ability to get copay assistance

Ongoing REACH support

REACH support does not end after you get access to SKYCLARYS. Registered pharmacists are here to support you throughout your SKYCLARYS treatment journey. Customized ongoing support services will be offered through the specialty pharmacy based on your individual needs and applicable program requirements.

For questions regarding SKYCLARYS, financial assistance, or access, you or your healthcare provider can call Biogen REACH at 1-844-987-3224, Monday through Friday, 8:30 am-8:00 pm ET

Explore financial support options that may be available to you through Biogen REACH†

†You are not required to enroll in Biogen REACH to receive a prescription for SKYCLARYS.

‡As of July 2024.

Whether or not you are insured, if SKYCLARYS is right for you, the REACH program may be able to help§

Biogen REACH is an informational resource that can help you explore affordability options.

Copay Program

Eligible commercially insured patients may have out-of-pocket costs as low as $0.§

Medicare Part D Extra Help

  • If you have limited income and resources, you may qualify for the Medicare Part D Low-Income Subsidy program, also known as Extra Help
  • Extra Help may cover a portion of your medication costs. Patients eligible for Extra Help may pay as little as $0 to $11.20
  • Apply for Extra Help online at www.ssa.gov/medicare/part-d-extra-help or by calling 1-800-772-1213

Uninsured Patients

If you are uninsured, please contact the REACH program at 1-844-987-3224 to determine financial assistance options.

§Subject to eligibility and program terms and conditions. REACH affordability options are not healthcare insurance.

There is an annual cap on the amount of assistance that patients can receive over a one-year period. Federal and state laws and other factors may prevent or otherwise restrict eligibility. People covered by Medicare, Medicaid, the VA/DoD, or any other federal plans are not eligible to enroll. You are eligible to enroll in the copay program for as long as it is offered and you are treated with SKYCLARYS.

Determining financial assistance options available to you
through Biogen REACH

How do I enroll in REACH?

Your doctor must complete and submit a Start Form on your behalf. To access support offerings through REACH, you also need to provide your signature on the patient portion of the Start Form.

What happens after the Start Form has been submitted?

After your doctor has submitted the Start Form, REACH will call you to provide an overview of the program and get your consent for participation. REACH will then research your health insurance to understand your coverage for SKYCLARYS and determine best next steps.

Save the REACH phone number in your phone so you don’t miss calls or texts about your SKYCLARYS refills: 1-844-987-3224

Where can I find
additional
information?

Once enrolled in Biogen REACH, patients can speak to a Lead Case Manager (LCM) to explore eligibility for financial assistance programs.

Learn more about access support by calling 1-844-987-3224, 8:30 am-8:00 pm ET, Monday through Friday (except holidays)

INDICATION AND IMPORTANT SAFETY INFORMATION

WHAT IS SKYCLARYS?

  • SKYCLARYS® (omaveloxolone) is used for the treatment of Friedreich ataxia in adults and children aged 16 years and older. It is not known if SKYCLARYS is safe and effective for use in children younger than 16 years of age

IMPORTANT SAFETY INFORMATION

What are the possible side effects of SKYCLARYS?

SKYCLARYS may cause serious side effects, including:

  • Increase in blood liver enzymes: Some people taking SKYCLARYS have had an increase in the level of liver enzymes in their blood. Your healthcare provider will do liver function tests
    • before you start taking SKYCLARYS
    • every month for the first 3 months after starting your treatment with SKYCLARYS
    • during certain times as needed while taking SKYCLARYS

If your liver enzymes increase, your healthcare provider may change your dose, stop treatment for some time, or completely stop treatment with SKYCLARYS.

  • Increase in a blood protein called B-Type Natriuretic Peptide (BNP). BNP tells how well your heart is working. Your healthcare provider will check your BNP levels before your treatment with SKYCLARYS. Tell your healthcare provider if you have signs and symptoms of your heart not working well such as too much fluid in your body (fluid overload). Signs and symptoms may include:
    • sudden weight gain (3 pounds or more of weight gain in 1 day, or 5 pounds or more of weight gain in 1 week)
    • swelling in your arms, hands, legs, or feet (peripheral edema)
    • fast heartbeat (palpitations)
    • shortness of breath

If you have symptoms of fluid overload that is considered a side effect of SKYCLARYS, your healthcare provider may stop treatment with SKYCLARYS.

  • Changes in cholesterol levels. Increases in low density lipoprotein cholesterol (LDL-C) or bad cholesterol and decreases in high density lipoprotein cholesterol (HDL-C) or good cholesterol have happened during treatment with SKYCLARYS. Your healthcare provider will check your cholesterol levels before and during your treatment with SKYCLARYS

The most common side effects of SKYCLARYS include: increased liver enzymes (ALT/AST), headache, nausea, stomach pain, tiredness, diarrhea, and muscle pain.

Before taking SKYCLARYS, tell your healthcare provider about all of your medical conditions, including if you:

  • have liver problems
  • have a history of heart problems, including heart failure
  • have a high level of fat in your blood (high blood cholesterol)
  • are pregnant or plan to become pregnant. It is not known if SKYCLARYS will harm your unborn baby. Women who use hormonal birth control should use another form of birth control such as a non-hormonal intrauterine system or an extra non-hormonal birth control such as condoms while using SKYCLARYS and for 28 days after stopping SKYCLARYS
  • Pregnancy exposure registry: There is a pregnancy registry for women who are pregnant and are taking SKYCLARYS. The purpose of this registry is to collect information about the health of you and your baby. Your healthcare provider can enroll you or you may enroll yourself by calling 1⁠-866⁠-609-⁠1785 or by sending an email to SkyclarysPregnancySurveillance@ppd.com
  • are breastfeeding or plan to breastfeed. It is not known if SKYCLARYS passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take SKYCLARYS

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements such as St. John’s Wort.

  • Taking SKYCLARYS with other medicines can cause serious side effects
  • SKYCLARYS may affect the way other medicines work, and other medicines may affect how SKYCLARYS works
  • Know the medicines you take. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine

What should I avoid while taking SKYCLARYS?

  • Do not drink grapefruit juice or eat grapefruit. These may change the amount of SKYCLARYS in your blood

These are not all the possible side effects of SKYCLARYS. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1⁠-800⁠-FDA⁠-⁠1088.

Please see full Prescribing Information, including Patient Information.

 

Intended for a US audience.

©2025 Biogen. All rights reserved.
SKY-US-0872 05/25